Rhythm Biosciences Limited (ASX:RHY)
Rhythm Biosciences (ASX:RHY) is an Australian biotech company working on a simple, affordable and effective blood test, ColoSTAT™, for the early detection of colorectal cancer.
Alphastation was engaged in Q2 2017 in preparation for its listing on the ASX in December 2017. Alphastation assisted Rhythm Biosciences including:
- Completion of the raw IPO prospectus for the company’s $9 million capital raising on the ASX including content drafting and refinement
- Defined communication strategy and positioning aligned to the Rhythm Biosciences corporate strategy
- Liaison with company management, Board of Directors, legal advisor to the offers and broker to ensure project was delivered before deadline
- Conceived diagrams and flowcharts to convey the technology, product and market story that went to external design team
- Completion of business plan to underpin the company growth plan
